These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome. Yamagishi S, Nakamura K, Takeuchi M. Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133 [Abstract] [Full Text] [Related]
33. Acarbose for the treatment of type II diabetes: the results of a Canadian multi-centre trial. Josse RG. Diabetes Res Clin Pract; 1995 Aug 21; 28 Suppl():S167-72. PubMed ID: 8529510 [Abstract] [Full Text] [Related]